Newark Beth Israel Medical Center, previously Newark Beth Israel Hospital, is a 665-bed quaternary care, teaching hospital located in Newark, New Jersey serving the healthcare needs for Newark and the Northern Jersey area.

There are 665 beds in Newark Beth Israel Medical Center.

During the past decade, Newark Beth Israel Medical Center conducted 104 clinical trials. In the 10-year time frame, 104 clinical trials started and 144 clinical trials were completed, i.e. on average, 138.5% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 66 clinical trials were completed. i.e. 220% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Newark Beth Israel Medical Center" #1 sponsor was "Children's Oncology Group" with 103 trials, followed by "National Cancer Institute (NCI)" with 57 trials sponsored, "Radiation Therapy Oncology Group" with 39 trials sponsored, "NSABP Foundation Inc" with 22 trials sponsored and "SWOG Cancer Research Network" with 22 trials sponsored. Other sponsors include 131 different institutions and companies that sponsored additional 82 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Newark Beth Israel Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 195 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "SWOG Cancer Research Network" with 8 trials as a collaborator, "North Central Cancer Treatment Group" with 7 trials as a collaborator and "Cancer and Leukemia Group B" with 6 trials as a collaborator. Other collaborators include 99 different institutions and companies that were collaborators in the rest 72 trials.

According to Clinical.Site data, the most researched conditions in "Newark Beth Israel Medical Center" are "Breast Cancer" (27 trials), "Leukemia" (14 trials), "Sarcoma" (12 trials), "Lymphoma" (11 trials) and "Prostate Cancer" (11 trials). Many other conditions were trialed in "Newark Beth Israel Medical Center" in a lesser frequency.

Most popular intervention types in "Newark Beth Israel Medical Center" are "Drug" (259 trials), "Other" (124 trials), "Biological" (98 trials), "Radiation" (95 trials) and "Procedure" (86 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (71 trials), "radiation therapy" (48 trials), "Cyclophosphamide" (46 trials), "cyclophosphamide" (33 trials) and "Vincristine Sulfate" (32 trials). Other intervention names were less common.

The vast majority of trials in "Newark Beth Israel Medical Center" are 323 trials for "All" genders, 39 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are 126 active trials in "Newark Beth Israel Medical Center". 1 are not yet recruiting, 38 are recruiting, 86 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 212 completed trials in Newark Beth Israel Medical Center, 2 suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Newark Beth Israel Medical Center, 19 "Phase 1" clinical trials were conducted, 101 "Phase 2" clinical trials and 181 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 41 trials that are defined as “Not Applicable".

Newark Beth Israel Medical Center has several departments that took part in Clinical trials: "Cancer Institute of New Jersey At Hamilton" - 93 trials, "Children's Specialized Hospital" - 2 trials, "Bristol Myers Squibb Children's Hospital at Robert Wood Johnson University Hospital" - 2 trials, "The Pediatric Specialty Center at Saint Barnabas" - 2 trials, "Rutgers Cancer Institute of New Jersey,201 Lyons Avenue" - 2 trials, "Children'S Specialized Hospital" - 2 trials